Image

A Phase II Study of Combining Talimogene Laherparepvec T-VEC (NSC-785349) and MK-3475 (Pembrolizumab) (NSC-776864) in Patients With Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy

Study on the Effects of an Investigational Medication Combination in Skin Cancer (Melanoma) Patients

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effects of a combination of investigational medications in patients with melanoma. Melanoma is a type of skin cancer that can spread to other parts of the body. The purpose of this study is to evaluate how well this combination works in patients who have already tried other treatments.

Participants in the study will receive a combination of two investigational medications. These medications will be given to see if they can provide a durable response in treating melanoma. The study will involve regular monitoring to assess the effects of the treatment.

  • Who can participate: Adults with stage IV or unresectable stage III melanoma can participate. Patients must not have disease suitable for local therapy, and those with treated brain metastases may join if there is no disease progression and no steroid use for 14 days prior.
  • Study details: Participants will receive a combination of investigational medications and be monitored to evaluate the response to the treatment. No payment will be provided for participation.
Print
Study details
    melanoma

TX9307

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.